Hamed Bahmani



Hamed is a research scientist and entrepreneur in digital health and neurotechnology based in Berlin, Germany. He is a visiting researcher at the Max Planck Institute for Biological Cybernetics in Tuebingen, Germany, and was previously a postdoctoral research fellow at the ZEISS Vision Science lab in the Institute for Ophthalmic Research at the University Hospital Tuebingen. He is affiliated with Bernstein Center for Computational Neuroscience (BCCN) and is past or current member of Vision Science Society (VSS), The Association for Research in Vision and Ophthalmology (ARVO), Society for Neuroscience (SfN), International Brain Research Organization (IBRO), International Myopia Institute (IMI), and research member and German Chair of Neuromarketing Science and Business Association (NMSBA).

Hamed holds double degree in electrical and biomedical engineering and received his doctoral degree in neurosciences from Max Planck Institute for Biological Cybernetics. His research interests include physiology of cognitive processes, in particular the neural correlates of higher visual functions like visual perception and attention. He has been awarded by several research grants including from the Volkswagen Foundation, Max Planck Institute, and German Federal Ministry of Education and Research. He is the founder and inventor, and currently the senior scientist at Dopavision GmbH. He leads and conducts research in myopia and neurophysiology of eye growth.